Cardiac Monitoring & Cardiac Rhythm Management Devices Market Worth $26.4 billion | MarketsandMarkets

CHICAGO, May 2, 2024 /PRNewswire/ -- Cardiac Monitoring & Cardiac Rhythm Management Devices Market in terms of revenue was estimated to be worth $21.3 billion in 2024 and is poised to reach $26.4 billion by 2029, growing at a CAGR of 4.3% from 2024 to 2029 according to a new report by MarketsandMarkets.

Market is driven by factors such as rising in aging population as the global population ages, there is a higher incidence of cardiac conditions associated with aging, such as atrial fibrillation and heart failure. On the other hand, Cost Constraints is expected to limit market growth to a certain extent in the coming years. As High upfront costs associated with cardiac monitoring and rhythm management devices may limit adoption, particularly in resource-constrained healthcare settings or for patients without adequate insurance coverage. Likewise, Continued advancements in technology offer opportunities for the development of more sophisticated and effective cardiac monitoring and rhythm management devices. Innovations such as miniaturization, wireless connectivity, artificial intelligence (AI), and remote monitoring capabilities can improve device performance, patient outcomes, and user experience. However, availability of lack of practiced professionals is anticipated to hinder market development.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55

Browse in-depth TOC on "Cardiac Monitoring & Cardiac Rhythm Management Devices Market"

424 - Tables
48 - Figures
313 - Pages

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Scope:

Report Coverage	Details
Market Revenue in 2024	$21.3 billion
Estimated Value by 2029	$26.4 billion
Growth Rate	Poised to grow at a CAGR of 4.3%
Market Size Available for	2022–2029
Forecast Period